Preclinical studies in rodents, as well as the efficacy study in client-owned dogs with spontaneous bladder cancer, show that vaccination against extracellular vimentin is safe, emphasizing the specificity of extracellular vimentin for tumor angiogenesis. The gene discussed is VIM; the disease is neoplasm.